Monthly Archives: August 2022

August 17, 2022

Advanced Proteome Therapeutics Manuscript Published in Bioconjugate Chemistry

2022-10-28T18:00:42-04:00

Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), reports that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), is dedicating additional resources to its SARS-CoV-2 protease inhibitor program.

Advanced Proteome Therapeutics Manuscript Published in Bioconjugate Chemistry2022-10-28T18:00:42-04:00
August 3, 2022

Advanced Proteome Therapeutics Receives Issued Patent

2022-10-28T18:01:35-04:00

Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), reports that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), is dedicating additional resources to its SARS-CoV-2 protease inhibitor program.

Advanced Proteome Therapeutics Receives Issued Patent2022-10-28T18:01:35-04:00
Go to Top